Clinical Trial Update: Preoperative Folfirinox, Radiation Therapy for Resectable Adenocarcinoma of the Pancreas [Phase 2]

View source ↗

Summary

Phase 2 trial update on preoperative Folfirinox plus radiation therapy for resectable pancreatic adenocarcinoma; study completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• FOLFIRINOX

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Pancreatic Cancer | Phase 2 | Status: COMPLETED | Results posted: 2020-08-10